Seelos Therapeutics Announces Pricing of $1.1 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules
Seelos Therapeutics Announces Acquisition of an Exclusive License to Intellectual Property from The UC Regents
Element79 Gold Corp. Announces Filing of NI 43-101 Technical Report for Gold Mountain Project, Nevada
